No description available.

Thesis (Ph. D.)--Ohio State University, 2006. / Title from first page of PDF file. Includes bibliographical references (p. 153-161).

Thesis (M.S.)--Rutgers University, 2009. / "Graduate Program in Physiology and Integrative Biology." Includes bibliographical references (p. 39-42).

Type 1 diabetes (T1D) is a chronic disease, characterised by the destruction of pancreatic beta cells, which results in lack of insulin expression. Most current therapies rely on the exogenous administration of recombinant insulin. Islet transplantation has been shown to be a more effective alternative treatment, but it is also limited by the lack of available islets for transplantation. The recently awarded work of Yamanaka and colleagues has shown that fully differentiated cells can be reprogrammed towards their pluripotent, undifferentiated state, through overexpression of a simple combination of four key transcritption factors (TFs). The studies presented in this thesis sought to investigate whether a combination of a small group of key pancreatic TFs would be able to drive both mouse embryonic stem cells (mES) and fully differentiated rat and human acinar cells of the pancreas towards insulin-producing cells. When administered in a timely manner to mES cells, the pancreatic TFs Pdx1 and MafA were able to induce the formation of cells that synthesised insulin de novo. Further studies aimed at investigating if a small number of TFs would be able to reprogramme the exocrine pancreatic cells towards insulin expressing cells, since, unlike endocrine cells, exocrine cells are highly abundant in the pancreas. Studies performed in both a rat exocrine cell line (AR42J-B13) and in human exocrine cells demonstrated that the combination of the TFs Pdx1, MafA, Ngn3 and Pax4 was able to generate glucose responsive β-like cells in both models. In addition, Pax4 was found to be determinant for the functionality of the generated β-cells. The functionality of these cells was further demonstrated by their ability to prevent the onset of hyperglycemia upon transplantation into a diabetic mouse model. The work presented in this thesis has shown that cultured exocrine cells may be a promising alternative for generating a replenishable supply of β-cells for transplantation.

Thesis (M.S.)--Worcester Polytechnic Institute. / Keywords: myoblasts; dexamethasone; infarction; cryoinjury; desmin; myosin heavy chain; differentiation. Includes bibliographical references (p. 54-59).

Thesis (Ph. D.)--Chemical and Biomolecular Engineering, Georgia Institute of Technology, 2006. / Harish Radhakrishna, Committee Member ; Mark Prausnitz, Committee Co-Chair ; Joseph Le Doux, Committee Chair ; Timothy Wick, Committee Member ; Richard Compans, Committee Member ; Athanassios Sambanis, Committee Member.

Thesis (Ph.D.)--Baylor University, 2006. / Includes bibliographical references (p. 100-115).

Thesis (Ph. D.)--University of Hong Kong, 2007. / Title proper from title frame. Also available in printed format.

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease characterized by persistent airway obstruction that is only partially reversible. It is the fourth leading cause of death and is predicted to be the third by 2030. The progression of the disease involves chronic inflammation, oxidative stress, excess protease activity, increased lung cell apoptosis and accelerated lung aging, but the exact pathogenesis is still unclear. The major cause of COPD is cigarette smoking(CS). Although COPD is associated with increasing social and economical burden, there have been few advances in pharmacological therapy of COPD. Mesenchymal stem cells (MSCs) are fibroblast-like multipotent stem cells which can be isolated from a broad range of sources including bone marrow (BM) and adipose tissue. Administration of BM-derivedMSCs (BM-MSC) or adipose tissue-derived MSCs was reported to attenuate CS-induced emphysema in murine models. Induced pluripotent stem cell-derived MSC (IPSC-MSC) are MSCs differentiated from induced pluripotent stem cells(IPSCs), which are pluripotent cells generated by somatic cell reprogramming in vitro. IPSC-MSCs have several advantages over BM-MSC, including more abundant sources and high capacity of doubling without loss of differentiation potency. A general exploration and comparison on the effects of human IPSC-MSC and BM-MSC treatments were carried out in a 56-day CS-exposed rat model. Compared to BM-MSC, IPSC-MSC showed a higher capacity to reside in lung tissue. The two treatments shared similar efficacy to attenuate CS-induced lung cell apoptosis, to restore CS-induced reduction of lungIL-10and to alleviate CS-induced elevation of systemic TGF-β1. In addition, IPSC-MSC was found to cause reduction in CS-induced elevation of systemic oxidative stress and reversal of CS-induced reduction of lung adiponectin. Furthermore, in order to understand the possible paracrine mechanism involved, human airway epithelial cells were treated with IPSC-MSC or BM-MSC-conditioned medium in a cell culture system in the presence of cigarette smoke medium (CSM). Potentiation rather than attenuation of CSM-induced release of pro-inflammatory cytokine IL-8, MCP-1 and IL-6 was observed with IPSC-MSC or BM-MSC conditioned medium. It is currently unknown whether cultured IPSC-MSCs or BM-MSCs will release pro-inflammatory mediators into the conditioned medium or not. In order to study CS-induced oxidative stress and inflammation in a short time frame, anacute (5-day) CS-exposed rat model was established in juvenile and adult groups. An age-dependent alteration of CS-induced oxidative and inflammatory responses was demonstrated in this model. In summary, our in vivo rat model provides a platform for elucidating the effects of stem cell treatment in CS-induced oxidative stress and inflammation, leading to lung damage. Our findings suggest that treatment of IPSC-MSC or BM-MSC might be able to slow down CS-induced disease progression, possibly through anti-oxidant, anti-inflammatory and anti-apoptotic properties. However, caution should be taken as our in vitro data revealed that conditioned medium from MSCs may provoke pro-inflammatory responses. Further studies on the regulation of the activity of MSCs in vivo will be needed before developing IPSC-MSC into cell therapies for COPD to halt the progression over time. / published_or_final_version / Medicine / Master / Master of Philosophy

Thesis (Ph. D.)--Ohio State University, 2005. / Available online via OhioLINK's ETD Center; full text release delayed at author's request until 2006 Dec 22